Kenya Achieves Milestone in Public Health by Eliminating Sleeping Sickness, According to WHO

Kenya has been declared free from sleeping sickness as a public health problem by the WHO, marking a major milestone in the fight against this parasitic disease in Africa.
Kenya has successfully eliminated sleeping sickness, also known as human African trypanosomiasis, as a significant public health concern, the World Health Organization announced on Friday. This achievement marks Kenya as the 10th country to reach this milestone, highlighting substantial progress in combating this disease across Africa.
Sleeping sickness is a parasitic disease transmitted by tsetse flies, which acquire the Trypanosoma brucei parasite from infected humans or animals. The disease is primarily endemic in sub-Saharan Africa and poses a severe health threat, especially to rural communities engaged in agriculture, fishing, animal husbandry, or hunting. Without effective treatment, the disease is often fatal.
The parasite can penetrate the blood-brain barrier, leading to neurological symptoms such as behavioral changes, confusion, sensory disturbances, and poor coordination. The characteristic sleep disturbances give the disease its name and typically appear in advanced stages. Historically, Kenya first reported cases in the early 20th century.
WHO Chief Tedros Adhanom Ghebreyesus congratulated the Kenyan government and its people for this landmark achievement, emphasizing that Kenya now joins other nations—including Benin, Chad, Equatorial Guinea, Ghana, Guinea, Ivory Coast, Rwanda, Togo, and Uganda—in eradicating sleeping sickness as a public health threat. This victory is a significant step toward eliminating neglected tropical diseases across the continent.
The elimination of sleeping sickness involves robust vector control, active disease surveillance, timely diagnosis, and treatment. This progress underscores the importance of sustained public health efforts and international cooperation in combating tropical diseases.
For more details, visit the original report at MedicalXpress.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Regional Variations in COVID-19 Deaths Across Europe During 2020 and 2021
An in-depth look at how COVID-19 caused significant regional differences in mortality across Europe during 2020 and 2021, emphasizing the importance of localized health data.
Inflammation Reactivates Dormant Cancer Cells, Leading to Recurrent Tumors
New research reveals how inflammation can awaken dormant cancer cells, leading to tumor recurrence and metastasis. Understanding these processes offers hope for better therapies to prevent cancer relapse.
Innovative Approach Targets Hepatitis B Virus Using RNA Interference Therapy
Recent advances in RNA interference therapeutics offer hope for a functional cure for hepatitis B, aiming to eliminate the virus's genetic material and restore immune function.